Home

Beta Drugs Ltd PE Ratio

Image

Beta Drugs Ltd

NSE: BETA

PE

43.5

Last updated on: Feb 21, 2025

Key Highlights

  • The P/E Ratio of Beta Drugs Ltd is 43.5 as of 21 Feb 25 .
  • The P/E Ratio of Beta Drugs Ltd changed from 4.1 on March 2020 to 32.5 on March 2024 . This represents a CAGR of 51.29% over 5 years.
  • The Latest Trading Price of Beta Drugs Ltd is ₹ 1649 as of 21 Feb 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Beta Drugs Ltd

No data available

Company Fundamentals for Beta Drugs Ltd

Image

Beta Drugs Ltd

NSE: BETA

Share Price

₹ 1649.3

-79.05 (-4.57%)

stock direction

Last updated on: Feb 21, 2025

Market Price of Beta Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Beta Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 20251649.3
20 Feb 20251728.35
19 Feb 20251690
18 Feb 20251685
17 Feb 20251738.75
14 Feb 20251779.4
13 Feb 20251842
12 Feb 20251667.25
11 Feb 20251741.35
10 Feb 20251807.35

SWOT Analysis Of Beta Drugs Ltd

Strength

3

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Beta Drugs Ltd

Asset Value vs Market Value of Beta Drugs Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PE Ratio of Beta Drugs Ltd Explained

1585

Market cap

21

Earnings

72.3X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Beta Drugs Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Beta Drugs Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Beta Drugs Ltd

No data available

* All values are in %

About Beta Drugs Ltd

  • Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
  • Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
  • Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
  • The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
  • The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.

Beta Drugs Ltd News Hub

Beta Drugs schedules AGM

Beta Drugs announced that the 19th Annual General Meeting (AGM) of the company will be held on 30 Se

Read more

02 Sept 24

Beta Drugs to conduct EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 12

Read more

21 Oct 24

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 6 November 2024 Powered b

Read more

04 Nov 24

Beta Drugs schedules EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 21

Read more

28 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions